Vox Markets Logo

See Today's AIM Risers Featuring Chamberlin Sale of of Exidor Limited to ASSA ABLOY for £10.00 million cash

10:37, 20th December 2018
Abraham Darwyne
AIM Risers
TwitterFacebookLinkedIn

See our roundup of today's AIM risers - see the full LSE winners & losers board here.

Chamberlin rises 39% to 97.5p a share

Chamberlin (CMH) FOLLOW announced that it has completed the sale of Exidor Limited to ASSA ABLOY Limited, for a total enterprise value of £10.00 million in cash.

The cash consideration represents approximately 180% of Chamberlin's market capitalisation based on closing mid-market price as at 18 December 2018.

Chairman, Keith Butler-Wheelhouse, commenting on the transaction said: "We believe that ASSA ABLOY, who are well positioned to support the ongoing growth and development of the business, represents the ideal owner for Exidor."

Read more here & follow CMH here: FOLLOW 

CMH price chart

Oracle Power (ORCP) rises 46% to 0.55p a share

Oracle Power (ORCP) FOLLOW provided an update to the MOU with Beijing Jingneng Power Company Limited, a Shanghai listed $3 billion market cap firm.

It proposed that PowerChina International Group Limited (BJPC) will take-up an equity interest of 78% in the combined lignite coal mine and mine mouth power plant in South-Eastern Sindh, Pakistan, while Oracle Power will retain 12.1%

Shahrukh Khan, CEO of Oracle, said: “The inclusion of our historic expenditure, several multiples of our current market capitalisation, as part of Oracle's contribution to the Project should help minimise dilution to shareholders in the PLC whilst retaining a significant interest in this sizeable asset.”

Read more here & follow ORCP here: FOLLOW

ORCP price chart

Midatech Pharma (MTPH) rises 8% to 6.75p a share

Midatech Pharma (MTPH) FOLLOW announced a Q-Sphera™ Microsphere Technology Partnership with a major regional pharmaceutical company.

The company is also in advanced discussions with a new strategic investor regarding a potential substantial investment in the Company and licence to develop the Group's products in Asia

Dr Craig Cook, Chief Executive Office of Midatech Pharma, said: "We are delighted to announce this partnership with a leading global pharmaceutical corporation.  This marks another important step in the development of our impressive Q-Sphera™ technology, after the positive clinical 'proof of concept' first-in-human study earlier this year in carcinoid cancer and acromegaly.”

Read more here & follow MTPH here: FOLLOW

MTPH price chart

Cenkos Securities (CNKS) rises 7% to 67.5p a share

Cenkos Securities (CNKS) FOLLOW after a difficult 12 months, which saw the resignation of its finance director, its chairman and its chief executive, in a trading update reported revenues have improve and beat current expectations.

Read more here & follow CNKS here: ​​​​​FOLLOW

CNKS price chart

See all today's AIM Risers here

 

TwitterFacebookLinkedIn

Disclaimer & Declaration of Interest

The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.

Recent Articles
Watchlist